Equanimity Ventures and Kotak Alternate Asset Managers led a pre-Series A funding round that brought $1.5 million to the healthtech firm Monitra Health.
The capital will support the expansion of Monitra Health’s cutting-edge upBeat remote heart monitoring system, which is intended for markets in India as well as abroad.
Read also – [Funding alert] Insurtech Startup Finhaat Secures $3 Mn Funding From Omnivore, Others
According to Monitra, over 10,000 patients have been effectively observed, and over 7.5 billion beating hearts have been analysed over 720,000 hours. The company states that it has global patents outstanding in the US, the EU, and Canada, and that it has patents in Australia and India, as reported by Entrackr.
Monitra Health aims to transform healthcare delivery by leveraging insights derived from medical data to tackle the world’s most urgent health issues.
Read also – [Funding alert] Proptech Platform HouseEazy Secures $1 Mn Seed Funding from Antler, Others
The upBeat® device from Monitra Health is assisting physicians in the diagnosis of the two most challenging issues in clinical cardiology: palpitations and unexplained fainting.
About Monitra Health
Working with medical device distributors and healthcare experts, Monitra Health employs a B2B2C approach under the direction of Ravi Bhogu. Intending to grow throughout India, the firm has set up distribution channels in Hyderabad, Kerala, and Maharashtra. A full-stack distant cardiac surveillance system designed for large scale has been developed by the Hyderabad-based business.
Read also – [Funding alert] Drug Discovery Platform Peptris Secures $1 Mn Funding from Speciale Invest, Others
